Drawing for PREMIX

USPTO serial 98439879

PREMIX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COUEY,JORDAN ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PREMIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian A. Tollefson

Brian A. Tollefson TollefsonIP326 First Street, #202529 Lee CircleAnnapolis, MD 21403

Goods and services

ClassDescriptionStatusFirst use
005Antihypertensives; Anesthetics for surgical and non-surgical use; Hormonal preparations; Pharmaceutical preparations for the treatment of asthma, shock, low blood pressure, and other adrenaline related conditions, namely, adrenal gland disorders, adrenal tumors, anxiety; General anesthetics; Prescription synthetic narcoticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 24, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 24, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 15, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2026EX1GSOU EXTENSION 1 GRANTED—
Jan 14, 2026EXT1SOU EXTENSION 1 FILED—
Jan 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Mar 21, 2025PETGPETITION TO REVIVE-GRANTED—
Mar 21, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Jan 24, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 24, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 20, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2024DOCKASSIGNED TO EXAMINER—
Jul 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 8, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance